Indian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...

America has released a new list of Chinese companies it believes support Beijing's military. Major firms like Alibaba, Baidu, and BYD are i...

The U.S. has updated its list of Chinese companies aiding Beijing's military, adding tech giants like Alibaba and Baidu, alongside chipmake...

US-China relations: Pentagon's update on Monday comes months after it briefly released -- then withdrew -- an earlier version of the list w...

A Shenzhen Airlines flight was canceled after a passenger alerted cabin crew to a suspected irregularity on the aircraft's wing before boar...

India's U17 women's team will face hosts China in the high-stakes quarter-finals of the AFC U17 Women's Asian Cup China 2026 at the Suzhou ...

Chinese military: It is not immediately clear if the companies have been added to the Pentagon's 1260H list of Chinese companies deemed mil...

The cost of “doing nothing” in markets can indeed be substantial, but that pales in comparison to the cost of complacency when the margin o...

The US government is concerned that certain Chinese biotech companies are contributing technology or research and development for use by Ch...

The blue-chip CSI300 index was up 0.39%, with its financial sector sub-index higher by 0.82%, the real-estate index up 1.66% and the health...

Test details for the dual-antibody treatment, which last week became the first approved COVID-19 antibody cocktail in China, would not be a...

China Evergrande Group plunged nearly 12% to its lowest in more than six years, after it warned of a risk of cross-default as real estate s...

The pharmaceutical industry increasingly relies for its profits on costly biologic drugs, made from living organisms that are tougher and m...

The change announced by the Hang Seng Indexes Company on Friday was made possible after the 50-year-old benchmark's publisher changed the r...

Syngene, an arm of Biocon, is expanding its capital investment as it waits to complete a 40-acre, $100-million research facility in Mangalo...

It hit an intraday high of Rs 318.20 over its issue price, before settling the day at Rs 310.40, up 24.16 per cent on the BSE.

In an interview with ET Now, Kiran Mazumdar-Shaw, CMD, Biocon, talks about the Syngene IPO and the growth prospects involved.